Global prosthetic joint infection treatment market is set to witness substantial growth in the coming years, with a forecasted Compound Annual Growth Rate (CAGR) of 6.85% from 2024 to 2031. According to a comprehensive market analysis, the market size is anticipated to surge from US$100.6 million in 2024 to an estimated US$160 million by the end of 2031.
For More Insights into the Market Read Predictive Maintenance Market Press Release at: https://www.fairfieldmarketresearch.com/press-release/global-passion-fruit-market For More Industry Insights Read: https://www.fairfieldmarketresearch.com/report/prosthetic-joint-infection-treatment-market
Key Growth Drivers 1. Increasing Incidence of Prosthetic Joint Surgeries: The rising prevalence of conditions such as osteoarthritis and rheumatoid arthritis, coupled with an ageing population, is driving the demand for prosthetic joint surgeries Globally. 2. Technological Advancements in PJI Treatment: Continuous innovation in treatment methodologies, including advanced antimicrobial coatings for prosthetic devices and improved diagnostic techniques, is enhancing treatment efficacy and patient outcomes. 3. Increased Healthcare Spending and Patient Awareness: Growing awareness among patients and healthcare providers about the risks associated with PJIs, coupled with increased healthcare spending, is leading to a higher demand for PJI treatment solutions. Major Growth Barriers 1. High Treatment Costs: The expense associated with PJI treatments, including long-term antibiotic therapies and surgery, poses a significant barrier, especially in low-income regions.